ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS MORE EFFECTIVE THAN TWICE-DAILY SALMETEROL/FLUTICASONE (SFC) IN REDUCING EXACERBATIONS IN COPD PATIENTS AT A HIGH RISK OF EXACERBATIONS: THE FLAME STUDY

Wedzicha J. A.; Chapman K. R.; Larbig M.; Patalano F.; Thach C.; Fogel R.; Banerji D.

首页> 外文期刊>Respirology : >ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS MORE EFFECTIVE THAN TWICE-DAILY SALMETEROL/FLUTICASONE (SFC) IN REDUCING EXACERBATIONS IN COPD PATIENTS AT A HIGH RISK OF EXACERBATIONS: THE FLAME STUDY

【24h】

ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS MORE EFFECTIVE THAN TWICE-DAILY SALMETEROL/FLUTICASONE (SFC) IN REDUCING EXACERBATIONS IN COPD PATIENTS AT A HIGH RISK OF EXACERBATIONS: THE FLAME STUDY

机译：在降低高危患病率的COPD患者中，一次致痛药/乙二醛（IND / GLY）比两次致死舒尔美特尔/氟替卡松（SFC）更有效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2016年第3期|共1页
作者
Wedzicha J. A.; Chapman K. R.; Larbig M.; Patalano F.; Thach C.; Fogel R.; Banerji D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献

1. ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS MORE EFFECTIVE THAN TWICE-DAILY SALMETEROL/FLUTICASONE (SFC) IN REDUCING EXACERBATIONS IN COPD PATIENTS AT A HIGH RISK OF EXACERBATIONS: THE FLAME STUDY [J] . Wedzicha J. A., Chapman K. R., Larbig M., Respirology : . 2016,第Suppla3期

机译：在降低高危患病率的COPD患者中，一次致痛药/乙二醛（IND / GLY）比两次致死舒尔美特尔/氟替卡松（SFC）更有效
2. INDACATEROL/GLYCOPYRRONIUM (IND/GLY) REDUCES THE RISK OF EXACERBATIONS VERSUS SALMETEROL/FLUTICASONE (SFC) IN MODERATE-TO-VERY SEVERE COPD PATIENTS IRRESPECTIVE OF PRIOR ICS/LABA/LAMA THERAPY: THE FLAME STUDY [J] . Wedzicha Jadwiga A., Mezzi Karen, Ayers Tim, Respirology : . 2017,第Suppla2期

机译：当前的IC / Laba / Lama治疗
3. INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS SUPERIOR TO SALMETEROL/FLUTICASONE (SFC) IN ASIAN PATIENTS WITH MODERATE-TO-VERY SEVERE COPD AT A HIGH RISK OF EXACERBATIONS: FLAME STUDY RESULTS [J] . Wedzicha J. A., Zhong N., Ichinose M., Respirology : . 2016,第Suppla3期

机译：在中度至非常严重COPD的亚洲患者中，吲达美洛尔/乙二醛（IND / GLY）比沙美特罗/氟替卡松（SFC）高
4. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study [O] . Jadwiga A Wedzicha, Nanshan Zhong, Masakazu Ichinose, 2017

机译：慢性阻塞性肺病高危亚裔患者中茚达特罗/格隆铵与沙美特罗/氟替卡松的比较：FLAME研究的结果

ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IS MORE EFFECTIVE THAN TWICE-DAILY SALMETEROL/FLUTICASONE (SFC) IN REDUCING EXACERBATIONS IN COPD PATIENTS AT A HIGH RISK OF EXACERBATIONS: THE FLAME STUDY

著录项

相似文献

相关主题

期刊订阅